A detailed history of Schonfeld Strategic Advisors LLC transactions in Nkarta, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 68,517 shares of NKTX stock, worth $285,030. This represents 0.0% of its overall portfolio holdings.

Number of Shares
68,517
Previous 400,100 82.88%
Holding current value
$285,030
Previous $4.33 Million 90.66%
% of portfolio
0.0%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$5.27 - $10.82 $1.75 Million - $3.59 Million
-331,583 Reduced 82.88%
68,517 $404,000
Q1 2024

May 15, 2024

BUY
$5.59 - $15.71 $2.24 Million - $6.29 Million
400,100 New
400,100 $4.33 Million
Q1 2023

May 15, 2023

BUY
$3.37 - $6.3 $42,462 - $79,380
12,600 New
12,600 $44,000

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $202M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.